These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16387003

  • 1. Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection.
    Hariprasad SM, Shah GK, Blinder KJ.
    Am J Ophthalmol; 2006 Jan; 141(1):200-1. PubMed ID: 16387003
    [Abstract] [Full Text] [Related]

  • 2. Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma.
    Frenkel RE, Mani L, Toler AR, Frenkel MP.
    Am J Ophthalmol; 2007 Jun; 143(6):1034-5. PubMed ID: 17524771
    [Abstract] [Full Text] [Related]

  • 3. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP, Haji SA, Frenkel RE.
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [Abstract] [Full Text] [Related]

  • 4. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
    Kim JE, Mantravadi AV, Hur EY, Covert DJ.
    Am J Ophthalmol; 2008 Dec; 146(6):930-4.e1. PubMed ID: 18775528
    [Abstract] [Full Text] [Related]

  • 5. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
    Lee EW, Hariprasad SM, Mieler WF, Newman TL, Apte RS.
    Am J Ophthalmol; 2007 Feb; 143(2):365-7. PubMed ID: 17258540
    [Abstract] [Full Text] [Related]

  • 6. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin).
    Falkenstein IA, Cheng L, Freeman WR.
    Retina; 2007 Oct; 27(8):1044-7. PubMed ID: 18040242
    [Abstract] [Full Text] [Related]

  • 7. Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.
    Boyer DS, Goldbaum M, Leys AM, Starita C, V.I.S.I.O.N. Study Group.
    Br J Ophthalmol; 2014 Nov; 98(11):1543-6. PubMed ID: 24997182
    [Abstract] [Full Text] [Related]

  • 8. Short-term intraocular pressure changes after intravitreal injection of bevacizumab.
    Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J.
    Can J Ophthalmol; 2007 Dec; 42(6):807-11. PubMed ID: 18026202
    [Abstract] [Full Text] [Related]

  • 9. Short-term intraocular pressure trends after intravitreal injection of bevacizumab (avastin).
    Mazzulla DA, Hariprasad SM, Jager RD, Mieler WF.
    Retin Cases Brief Rep; 2008 Dec; 2(3):234-5. PubMed ID: 25390096
    [Abstract] [Full Text] [Related]

  • 10. [Clinical experience with pegaptanib in the treatment of age-related macular degeneration (AMD)].
    Thelen U.
    Klin Monbl Augenheilkd; 2010 Jan; 227(1):67-72. PubMed ID: 19842076
    [Abstract] [Full Text] [Related]

  • 11. [Clinical experience in the treatment of neovascular age-related macular degeneration with pegaptanib].
    Maier M, Feucht N, Huebner M, Lohmann C.
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):582-7. PubMed ID: 18516780
    [Abstract] [Full Text] [Related]

  • 12. Intraocular pressure effects of pegaptanib (macugen) injections in patients with and without glaucoma.
    Lanzl IM, Maier M, Feucht N, Lohmann CP, Kotliar KE.
    Am J Ophthalmol; 2008 Jan; 145(1):185; author reply 186. PubMed ID: 18154762
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab.
    Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J.
    Eye (Lond); 2009 Jan; 23(1):181-5. PubMed ID: 17693999
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Progression of choroidal neovascularization following injection of pegaptanib sodium (macugen) in two eyes with neovascular age-related macular degeneration.
    Williams AJ, Fekrat S.
    Am J Ophthalmol; 2006 Oct; 142(4):683-4. PubMed ID: 17011868
    [Abstract] [Full Text] [Related]

  • 17. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S, Kaplowitz K, Brubaker JW, Updike PG, Collins AT, Walsh AC, Romano PW, Sadda SR.
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [Abstract] [Full Text] [Related]

  • 18. The effect of intravitreal triamcinolone on intraocular pressure.
    Kramar M, Vu L, Whitson JT, He YG.
    Curr Med Res Opin; 2007 Jun; 23(6):1253-8. PubMed ID: 17559723
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E, Kara N, Yazici AT, Yuksel K, Demirok A, Yilmaz OF, Demir S.
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [Abstract] [Full Text] [Related]

  • 20. Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a prospective study.
    Knip MM, Välimäki J.
    Acta Ophthalmol; 2012 May; 90(3):254-8. PubMed ID: 20456259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.